En DE FR ES PL
Ultrix - instructions for use, reviews, analogs and forms of release (injections in ampoules of the influenza vaccine for intramuscular injection or vaccination) of a drug for the treatment and prevention of infection in adults, children and in pregnancy

Ultrix - instructions for use, reviews, analogs and forms of release (injections in ampoules of the influenza vaccine for intramuscular injection or vaccination) of a drug for the treatment and prevention of infection in adults, children and in pregnancy

In this article, you can read the instructions for using the drug Ultrix. Presented are reviews of visitors to the site - consumers of this medication, as well as the opinions of physicians specialists on the use of Ultrix in their practice. A big request is to actively add their feedback on the drug: the medicine helped or did not help get rid of the disease, which were observed complications and side effects, possibly not declared by the manufacturer in the annotation. Analogues of Ultrix in the presence of existing structural analogs.Use for the treatment and prevention of influenza in adults, children, as well as during pregnancy and lactation. Composition of the vaccine against influenza.

 

Ultrix - the influenza inactivated split vaccine is a mixture of highly purified protective surface and internal antigens of influenza A (H1N1 and H3N2) and type B viruses.

 

The vaccine is well tolerated by adults, forms high specific immunity against influenza type A and B. After immunization, immunity persists for up to 12 months. High efficiency of the vaccine is ensured by the presence in it of both surface and internal antigens of the influenza virus.

 

Composition

 

Hemagglutinin and neuraminidase of the following viral strains: A (H3N2) + A (H1N1) + B + auxiliary substances.

 

Indications

  • specific prevention of influenza in humans.

 

Annual vaccination is recommended for people with a high risk of complications and people who are at a high risk of influenza or who are infected by other people:

  • persons suffering from chronic physical illness;
  • often ill ARI;
  • medical workers;
  • employees in the service sector;
  • transport workers;
  • employees of educational institutions.

 

Forms of release

 

Solution for intramuscular injection (injections in ampoules for injection).

 

Instructions for use and technique of vaccination

 

Vaccination is carried out annually in the autumn-winter period. It is possible to vaccinate at the beginning of an epidemic rise in the incidence of influenza.

 

The vaccine is injected intramuscularly into the upper third of the outer surface of the shoulder (in the deltoid muscle).

 

Opening of ampoules and the vaccination procedure are carried out with strict adherence to aseptic and antiseptic rules: before opening the ampoule, the neck of the ampoule is wiped with cotton wool soaked with 70% ethyl alcohol, the ampoule is opened, the vaccine is taken into a disposable syringe and excess air is removed from the syringe. Alcohol rubs the skin at the injection site. The drug in the opened ampoule is not subject to storage.

 

On the day of vaccination, the vaccinated should be examined by a physician (paramedic) with obligatory thermometry. At a temperature above 37 degrees Celsius, there is no vaccination.

 

The preparation is not suitable for use in ampoules with broken integrity or marking, with changing physical properties (color, transparency), expired shelf life, violation of storage requirements.

 

Side effect

 

Local and general reactions to the introduction of the vaccine are largely absent.

 

Rarely at the injection site, there may be reactions in the form of soreness, redness and swelling of the skin.

 

Individuals may have general reactions in the form of increased fatigue, headache, dizziness, subfebrile temperature, runny nose, pharyngitis, coughing, arthralgia, myalgia, nausea. These reactions usually disappear on their own in 1-3 days.

 

In extremely rare cases with high individual sensitivity, allergic reactions can be observed.

 

Contraindications

  • allergic reactions to previous vaccinations, chicken protein and vaccine components;
  • acute febrile conditions or exacerbation of a chronic disease.

 

For non-severe acute respiratory viral infections, acute intestinal diseases, vaccination is carried out after normalizing the temperature.

 

Vaccinations are carried out after recovery (remission).

 

Application in pregnancy and lactation

 

Clinical studies in this group of patients were not conducted.

 

Use in children

 

The use of the Ultrix vaccine is allowed from the age of 12 without age limitation.

 

special instructions

 

Do not administer intravenously.In the offices where the vaccination is carried out, it is necessary to have medicines for carrying out anti-shock measures and stopping the anaphylactic reaction.

 

The vaccinated should be monitored by a health worker within 30 minutes after immunization.

 

Drug Interactions

 

Ultrix vaccine can be administered against the background of basic therapy of the underlying disease.

 

The vaccine can be used concomitantly with other inactivated vaccines. This should take into account contraindications to each of the vaccines used, the drugs must be injected into different parts of the body with different syringes.

 

Analogues of Ultritis

 

Ultrix has no structural analogs for the active substance. A set of antigenic components of different influenza vaccines can change in epidemiological seasons of different years, depending on the detected strains of the virus.

 

Vaccines against influenza:

  • Agrippal S1;
  • The antigen of the influenza A virus is allantoic;
  • Antigen of the influenza virus type A allantoic (H1N1);
  • Antigen of the influenza virus type A allantoic (H3N2);
  • Antigen of the influenza virus type B;
  • Antigen of the influenza virus type B allantoic;
  • Begrivac;
  • Vaxigrip;
  • Vaccine influenza inactivated;
  • Grippovac;
  • Grippol;
  • Grippol Neo;
  • Inflexal;
  • Influvac;
  • Microflu;
  • Monovalent substance of influenza type B virus (split, inactivated);
  • Monovalent substance of influenza A virus (split, inactivated);
  • Pandeflu;
  • Совигрипп Vaccine influenza inactivated subunit;
  • Ultrrix Vaccine influenza inactivated split;
  • Fluuarix;
  • Fluvaxin.

 

Analogues on the curative effect (means for treating influenza and its symptoms):

  • Alfaron;
  • Amizon;
  • Amiksin;
  • Anaferon;
  • Anaferon child;
  • Antigrippin;
  • Arbidol;
  • Aflubin;
  • Aeros;
  • Baxin;
  • Bronchicum;
  • Bronchicum cough syrup;
  • Vaxigrip;
  • Vaccine influenza inactivated eluate-centrifuge liquid;
  • Viferon;
  • Hexapneumine;
  • Genferon Light;
  • Hydrel;
  • Homeoantigrippin;
  • Homeopathy;
  • Grippferon;
  • Ibuprofen;
  • Ibufen;
  • Isoprinosine;
  • Immunal;
  • Immunoglobulin;
  • Immunorm;
  • Ingavirin;
  • Inflexal;
  • Influbene;
  • Influenza;
  • Influcid;
  • IRS 19;
  • Kagocel;
  • Carinate;
  • Codipron;
  • Coldrex;
  • Lavomax;
  • Levopron;
  • Libexin;
  • Linkas;
  • Neovir;
  • Nomides;
  • Nurofen;
  • Nurofen for children;
  • Orvire;
  • Oscillococcinum;
  • Paxelidine;
  • Pliwalgin;
  • Polyoxidonium;
  • Reaferon EU Lipint;
  • Remantadine;
  • Rimantadine;
  • Stopgripan forte;
  • Tamiflu;
  • Fervex;
  • Floustop;
  • Fluuarix;
  • Cycloferon;
  • Cigapan;
  • Ergoferon;
  • Echinacea.

Similar medicines:

Other medicines:

Reviews (0):

Rules for publishing reviews and visitor questions